- Filed
- Feb 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 10, 2026 | 12.61M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 13.86M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 13.92M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 13.42M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 11.95M sh |
| Capex | Q2 2026 · Dec 31, 2025 | $789.54K |
| Capex | Q2 2026 · Dec 31, 2024 | $428.09K |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | $2.11M |
| Operating Cash Flow | Q2 2026 · Dec 31, 2024 | $3.84M |
| Long Term Debt | Q2 2026 · Dec 31, 2025 | $49.46K |
| Long Term Debt | Q2 2026 · Jun 30, 2025 | $481.26K |
| Short Term Debt | Q2 2026 · Dec 31, 2025 | $560.8K |
| Short Term Debt | Q2 2026 · Jun 30, 2025 | $875.35K |
| Cash And Equivalents | Q2 2026 · Dec 31, 2025 | $21.06M |
| Cash And Equivalents | Q2 2026 · Jun 30, 2025 | $20.32M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $46.07M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $43.67M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $41.04M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $36.41M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $32.56M |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | $22.42M |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $14.05M |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $13.78M |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $27.04M |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $28.16M |
| Current Assets | Q2 2026 · Dec 31, 2025 | $41.82M |
| Current Assets | Q2 2026 · Jun 30, 2025 | $37.05M |
| Total Assets | Q2 2026 · Dec 31, 2025 | $73.12M |
| Total Assets | Q2 2026 · Jun 30, 2025 | $69.21M |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | $0.15 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | $0.30 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | $0.10 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | $0.29 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | $0.16 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | $0.34 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | $0.11 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | $0.32 |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $6.11M |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $12.21M |
| Sga Expense | Q2 2026 · Dec 31, 2024 | $4.35M |
| Sga Expense | Q2 2026 · Dec 31, 2024 | $8.32M |
| Net Income | Q2 2026 · Dec 31, 2025 | $2.04M |
| Net Income | Q2 2026 · Dec 31, 2025 | $4.23M |
| Net Income | Q2 2026 · Sep 30, 2025 | $2.19M |
| Net Income | Q2 2026 · Dec 31, 2024 | $1.4M |
| Net Income | Q2 2026 · Dec 31, 2024 | $3.49M |
| Net Income | Q2 2026 · Sep 30, 2024 | $2.09M |
| Operating Income | Q2 2026 · Dec 31, 2025 | $2.56M |
| Operating Income | Q2 2026 · Dec 31, 2025 | $5.25M |
| Operating Income | Q2 2026 · Dec 31, 2024 | $1.66M |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | $4.33M |
| Revenue | Q2 2026 · Dec 31, 2025 | $19.18M |
| Revenue | Q2 2026 · Dec 31, 2025 | $38.59M |
| Revenue | Q2 2026 · Dec 31, 2024 | $13.64M |
| Revenue | Q2 2026 · Dec 31, 2024 | $27.64M |